In focus
Latest feed
ELVN Shares Poised for Best Weekly Gain Since March Amid FDA Development Pathway News
ADC Therapeutics Shares Face Brutal Sell-Off After Disappointing Clinical Trial Results
Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation
The Jemperli Royalty Rumble: GSK's Tesaro Unit Takes AnaptysBio to Court
